Authors:
Kaminski, MS
Zelenetz, AD
Press, OW
Saleh, M
Leonard, J
Fehrenbacher, L
Lister, TA
Stagg, RJ
Tidmarsh, GF
Kroll, S
Wahl, RL
Knox, SJ
Vose, JM
Citation: Ms. Kaminski et al., Pivotal study of iodine I 131 Tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas, J CL ONCOL, 19(19), 2001, pp. 3918-3928
Citation: Rj. Lederman et al., Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG), NUCL MED C, 22(7), 2001, pp. 747-753
Authors:
Koral, KF
Dewaraja, Y
Clarke, LA
Li, J
Zasadny, KR
Rommelfanger, SG
Francis, IR
Kaminski, MS
Wahl, RL
Citation: Kf. Koral et al., Tumor-absorbed-dose estimates versus response in tositumomab therapy of previously untreated patients with follicular non-Hodgkin's lymphoma: Preliminary report, CANC BIO R, 15(4), 2000, pp. 347-355
Authors:
Vose, JM
Wahl, RL
Saleh, M
Rohatiner, AZ
Knox, SJ
Radford, JA
Zelenetz, AD
Tidmarsh, GF
Stagg, RJ
Kaminski, MS
Citation: Jm. Vose et al., Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas, J CL ONCOL, 18(6), 2000, pp. 1316-1323
Citation: H. Minn et al., Effect of nitroimidazole sensitizers on in vitro glycolytic metabolism of hypoxic squamous cell carcinoma, ACTA ONCOL, 39(2), 2000, pp. 199-205
Authors:
Koral, KF
Dewaraja, Y
Li, J
Barrett, CL
Regan, DD
Zasadny, KR
Rommelfanger, SG
Francis, IR
Kaminski, MS
Wahl, RL
Citation: Kf. Koral et al., Initial results for hybrid SPECT-conjugate-view tumor dosimetry in I-131-anti-B-1 antibody therapy of previously untreated patients with lymphoma, J NUCL MED, 41(9), 2000, pp. 1579-1586
Authors:
Torizuka, T
Zasadny, KR
Kison, PV
Rommelfanger, SG
Kaminski, MS
Wahl, RL
Citation: T. Torizuka et al., Metabolic response of non-Hodgkin's lymphoma to I-131-anti-B1 radioimmunotherapy: Evaluation with FDG PET, J NUCL MED, 41(6), 2000, pp. 999-1005
Authors:
Higashi, T
Fisher, SJ
Brown, RS
Nakada, K
Walter, GL
Wahl, RL
Citation: T. Higashi et al., Evaluation of the early effect of local irradiation on normal rodent bone marrow metabolism using FDG: Preclinical PET studies, J NUCL MED, 41(12), 2000, pp. 2026-2035
Authors:
Kaminski, MS
Estes, J
Zasadny, KR
Francis, IR
Ross, CW
Tuck, M
Regan, D
Fisher, S
Gutierrez, J
Kroll, S
Stagg, R
Tidmarsh, G
Wahl, RL
Citation: Ms. Kaminski et al., Radioimmunotherapy with iodine I-131 tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience, BLOOD, 96(4), 2000, pp. 1259-1266
Authors:
Koral, KF
Li, J
Dewaraja, Y
Barrett, CL
Regan, DD
Zasadny, KR
Rommelfanger, SG
Francis, IR
Kaminski, MS
Wahl, RL
Citation: Kf. Koral et al., I-131 anti-B1 therapy/tracer uptake ratio using a new procedure for fusionof tracer images to computed tomography images, CLIN CANC R, 5(10), 1999, pp. 3004S-3009S
Citation: Cs. John et al., Synthesis, in vitro pharmacologic characterization, and preclinical evaluation of N-[2-(1 '-piperidinyl)ethyl]-3-[I-125]iodo-4-methoxybenzamide (P[I-125]MBA) for imaging breast cancer, NUCL MED BI, 26(4), 1999, pp. 377-382
Citation: Id. Kirkwood et al., Painful Schmorl's node: Another cause of vertebral photopenia on indium-111-labeled leukocyte scintigraphy, CLIN NUCL M, 24(3), 1999, pp. 206-208
Authors:
Jamadar, DA
Kazerooni, EA
Martinez, FJ
Wahl, RL
Citation: Da. Jamadar et al., Semi-quantitative ventilation perfusion scintigraphy and single-photon emission tomography for evaluation of lung volume reduction surgery candidates: description and prediction of clinical outcome, EUR J NUCL, 26(7), 1999, pp. 734-742
Citation: Y. Sugawara et al., Uptake of positron emission tomography tracers in experimental bacterial infections: a comparative biodistribution study of radiolabeled FDG, thymidine, L-methionine, Ga-67-citrate, and I-125-HSA, EUR J NUCL, 26(4), 1999, pp. 333-341
Citation: Rr. Raylman et al., Capabilities of two- and three-dimensional FDG-PET for detecting small lesions and lymph nodes in the upper torso: a dynamic phantom study, EUR J NUCL, 26(1), 1999, pp. 39-45
Citation: Pd. Shreve et al., Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants, RADIOGRAPHI, 19(1), 1999, pp. 61-77
Citation: Y. Sugawara et al., Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results, J NUCL MED, 40(9), 1999, pp. 1456-1462
Citation: Rs. Brown et al., Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer, J NUCL MED, 40(4), 1999, pp. 556-565
Citation: A. Tonakie et al., Reproducibility of lymphoscintigraphic drainage patterns in sequential Tc-99m human serum albumin and Tc-99m sulfur colloid studies: Implications forsentinel node identification in melanoma, SURGERY, 126(5), 1999, pp. 955-962